Eversight is a global nonprofit eye bank with a mission to restore sight and prevent blindness through the healing power of donation, transplantation and research.

One billion people are coping with preventable vision loss globally. This includes 12 million who suffer from corneal blindness, making this condition the fourth leading cause of blindness worldwide.

Eversight and our many dedicated partners are working to address this global burden and help make vision a reality for more people worldwide.

Our Focus

Donation

Restored sight begins with the generosity of eye donors and their families.

Learn more

Transplantation

Cornea transplants give people the chance to see a bright future.

Learn more

Research

Groundbreaking discoveries transform the future of vision therapies.

Learn more

Global vision

Our impact gives hope to people in need around the world.

Learn more

News & Stories

Top workplaces culture excellence awards
Eversight earns five Culture Excellence awards for third consecutive year
ANN ARBOR, Mich., April 23, 2025 – Eversight, a global leader in the field of eye... read more
ANN ARBOR, Mich., April 23, 2025 – Eversight, a global leader in the field of eye... read more Full Story
Eversight’s Board Chair Kathy Zelenock
A record-breaking year
As we reflect on the past year, our Board of Directors is overwhelmed with gratitude and... read more
As we reflect on the past year, our Board of Directors is overwhelmed with gratitude and... read more Full Story
Eversight staff attend World Cornea Congress
Connection, innovation & education: Eversight at WCC2025
April 16, 2025 – Eversight team members recently attended the 2025 World Cornea... read more
April 16, 2025 – Eversight team members recently attended the 2025 World Cornea... read more Full Story
Global aid to Guatemala
Bridging borders: Advancing eye care through global education and training
Millions of people around the world struggle with vision loss due to limited access to... read more
Millions of people around the world struggle with vision loss due to limited access to... read more Full Story